文献速递甲状腺疾病

单次射频消融治疗良性甲状腺结节的长期疗效:5年纵向观察研究

Long-Term Efficacy of a Single Session of RFA for Benign Thyroid Nodules: A Longitudinal 5-Year Observational Study.
PubMed 文献 · J Clin Endocrinol Metab · 2019-01-01

结果显示结节体积在1年时即显著缩小并持续至5年,观察期末缩小达67%;小于10 mL的结节反应最佳(早期缩小79%,5年缩小81%),患者症状显著改善。结论认为RFA可持久缩小良性甲状腺结节并改善主观症状,可作为手术的替代选择。

要点

  • 单次RFA后结节体积在1年时显著缩小并持续至5年,观察期末缩小67%。
  • 小于10 mL的结节反应最佳,早期缩小79%、5年缩小81%。
  • 患者压迫和美容相关症状显著改善,支持RFA作为手术替代。

核心结论

  • 单次RFA可持久缩小良性甲状腺结节并改善主观症状,确立其作为手术替代方案的可靠性。

主要发现

  • 结节体积在1年时即出现早期显著缩小,并持续至5年。
  • 观察期末结节缩小达67%。
  • 小于10 mL的结节反应最佳,早期缩小79%、5年缩小81%。
  • 患者症状显著减轻。

关键数值与推荐

  • RFA采用移动射击技术,局部麻醉后进行,中位功率55W,中位时间14分钟,使用内部冷却18号电极、活性尖端10 mm。

临床怎么用

  • 对于良性甲状腺结节,尤其小于10 mL者,单次RFA可作为一种持久有效的替代手术的治疗选择。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

CONTEXT: Radiofrequency ablation (RFA) of benign thyroid nodules has been gaining consensus. However, no solid information on its long-term efficacy is available. OBJECTIVE: To analyze the long-term results of single-session RFA. DESIGN: Retrospective longitudinal observational study. SETTING: Primary care center. PATIENTS OR OTHER PARTICIPANTS: Adult outpatients who underwent a single-session RFA and posttreatment follow-up of least 3 years. INTERVENTION: Ultrasound-guided RFA was performed after local anesthesia by "moving-shot" technique. RFA was performed with a median power of 55W and a median time of 14 minutes with an internally cooled 18-gauge electrode with an active 10-mm tip. MAIN OUTCOME MEASURES: Objective (trend of nodule volume) and subjective (compressive and cosmetic concerns) response to RFA were evaluated. Continuous variables were analyzed by the Wilcoxon and ANOVA test and their correlations by using the Spearman test. Categorical variables were compared by Pearson χ2 test. RESULTS: Two hundred and fifteen patients were included. An early significant reduction of nodule volume was found at 1 year, lasting up to 5 years. A 67% nodule shrinkage was observed at the end of the observation period. The best response was recorded in nodules below 10 mL (79% reduction early and 81% at 5 years). Patients' symptoms were significantly reduced. CONCLUSIONS: This study, by demonstrating a durable shrinkage of benign thyroid nodules treated by RFA with an improvement of subjective symptoms, establishes the reliability of RFA as alternative to surgery in the management of thyroid nodules, thus representing a remarkable novelty for clinical practice.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. Deandrea M, Trimboli P, Garino F, et al. Long-Term Efficacy of a Single Session of RFA for Benign Thyroid Nodules: A Longitudinal 5-Year Observational Study. J Clin Endocrinol Metab. 2019. PMID: 30860579. doi:10.1210/jc.2018-02808

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。